E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 3/13/2013 in the Prospect News Investment Grade Daily.

New Issue: GlaxoSmithKline prices $3 billion of three-, 10-, 30-year notes

By Andrea Heisinger

New York, March 13 - GlaxoSmithKline Capital Inc. priced $3 billion of senior notes (A1/A+/) in three maturities on Wednesday, a market source said.

A $1.25 billion tranche of 0.7% three-year notes priced at 99.87 to yield 0.744% with a spread of Treasuries plus 35 basis points. Guidance was in the 40 bps area.

There is a make-whole call at Treasuries plus 5 bps.

There was $1.25 billion of 2.8% 10-year notes sold at 98.992 to yield 2.917% with a spread of 90 bps over Treasuries. Price talk was in the 95 bps area.

The tranche carries a make-whole call at Treasuries plus 15 bps.

Finally, there was $500 million of 4.2% 30-year bonds priced at 98.672 to yield 4.279% with a spread of Treasuries plus 105 bps. The bonds were talked in the 110 bps area.

There is a make-whole call at Treasuries plus 17.5 bps on the bonds.

Bookrunners were Deutsche Bank Securities Inc., Goldman Sachs & Co., J.P. Morgan Securities LLC and UBS Securities LLC.

Proceeds will be used for general corporate purposes, including refinancing existing debt.

The notes are guaranteed by Brentford, England-based GlaxoSmithKline plc.

Glaxo last tapped the U.S. bond market with a $5 billion offering in three parts on May 2, 2012. That trade included a 0.75% three-year note sold at Treasuries plus 45 bps and a 2.85% 10-year note priced at 100 bps over Treasuries.

The global health care company for pharmaceuticals and consumer health products has its U.S. headquarters in Wilmington, Del.

Issuer:GlaxoSmithKline Capital Inc.
Guarantor:GlaxoSmithKline plc
Issue:Senior notes
Amount:$3 billion
Bookrunners:Deutsche Bank Securities Inc., Goldman Sachs & Co., J.P. Morgan Securities LLC, UBS Securities LLC
Trade date:March 13
Ratings:Moody's: A1
Standard & Poor's: A+
Three-year notes
Amount:$1.25 billion
Maturity:March 18, 2016
Coupon:0.7%
Price:99.87
Yield:0.744%
Spread:Treasuries plus 35 bps
Call:Make-whole at Treasuries plus 5 bps
Price talk:40 bps area
10-year notes
Amount:$1.25 billion
Maturity:March 18, 2023
Coupon:2.8%
Price:98.992
Yield:2.917%
Spread:Treasuries plus 90 bps
Call:Make-whole at Treasuries plus 15 bps
Price talk:95 bps area
30-year bonds
Amount:$500 million
Maturity:March 18, 2043
Coupon:4.2%
Price:98.672
Yield:4.279%
Spread:Treasuries plus 105 bps
Call:Make-whole at Treasuries plus 17.5 bps
Price talk:110 bps area

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.